MHRA Explains Its Approach To New 'Safety Features' In 2019

The MHRA has set out its position on those aspects of the new “safety feature” rules for prescription drugs where member states have flexibility to choose their options, such as the information to be included in the “unique identifier” and the conditions for “checking out” medicines from the verification system. The European Medicines Verification System is being introduced as part of the EU Falsified Medicines Directive.

Verification Log In User Password Register Concept
The UK MHRA has explained its position on aspects of the EU drug verification system

The UK regulator, the MHRA, says that the safety feature to be affixed to medicine packs as of February next year will not have to include a national reimbursement or other identification number, but that other information can be included provided it has been appropriately assessed by the agency. It has also explained its position on decommissioning of products from the EU verification system.

Under the European Medicines Verification System, which is being introduced as part of the EU Falsified Medicines Directive, all prescription...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from Pink Sheet